HYPERCALCEMIA in critically ill patients



HYPERCALCEMIA.




Hypercalcemia is rare in critically ill patients, estimated to be present 
in between 1% and 15% of ICU patients. Defined as an increase in serum calcium above 10.4 mg/dL (2.60 mmol/L), hypercalcemia usually is caused by excessive bone resorption. 


Most common causes:



  • Hyperparathyroidism 
  • Humoral hypercalcemia of malignancy
  • Sarcoidosis
  • Prolonged immobilization
  • Medications (e.g., thiazide diuretics).




Clinical findings:


Mild hypercalcemia is usually asymptomatic. However, patients 
with circulating Ca2+ above 12 mg/dL may manifest symptoms:


  • Cardiovascular: hypotension, hypovolemia, and shortened QT interval
  • Profound skeletal muscle weakness may result. Seizures, however, are rare

 Management:

    The treatment of hypercalcemia should be directed at the underlying 
medical condition. Saline infusion and diuresis are indicated in symptomatic patients and when the serum calcium level rises above 14 mg/dL (3.5 mmol/L). 
For patients with underlying malignancy, treatment with salmon calcitonin, pamidronate, or plicamycin may be necessary. These agents act to inhibit bone resorption. 
Hydrocortisone can also be used in combination with calcitonin to treat hypercalcemia associated with multiple myeloma.

Popular posts from this blog

Ketamine: The Past, Present, and Potential Future of an Anesthetic Drug

Fast track anesthesia approaches